# FDA Inspection 731947 - Oklahoma Blood Institute - June 28, 2011

Source: https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/71ff3bbf-2a90-4dd1-9305-5c2bb67b052d
Source feed: FDA_Inspections

> FDA Inspection 731947 for Oklahoma Blood Institute on June 28, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 731947
- Company Name: Oklahoma Blood Institute
- Inspection Date: 2011-06-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 822339 - 2013-03-01](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/4a762964-d4eb-491f-8b96-9414b14ed087)
- [FDA Inspection 606578 - 2009-08-07](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/7f0b32be-0424-4282-b77e-4c7cd558ee25)

Company: https://www.keypedia.com/companies/oklahoma-blood-institute/ca713402-ffa5-4417-ac82-396289b375c9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d